Cecilia L Bergeria

发表

Differences in patient-reported and observer-rated opioid withdrawal symptom etiology, time course, and relationship to clinical outcome.

E. Strain, Kelly E. Dunn, A. S. Huhn, 2020, Drug and alcohol dependence.

The impact of naturalistic cannabis use on self-reported opioid withdrawal.

Kelly E. Dunn, A. S. Huhn, Cecilia L Bergeria, 2020, Journal of substance abuse treatment.

Preventing relapse after incentivized choice treatment: A laboratory model

M. Bouton, Eric A Thrailkill, Danielle R. Davis, 2017, Behavioural Processes.

Investigating tobacco withdrawal in response to reduced nicotine cigarettes among smokers with opioid use disorder and other vulnerabilities.

M. Stitzer, J. Hughes, S. Higgins, 2020, Experimental and clinical psychopharmacology.

Evaluation of Stigma Related to Perceived Risk for Coronavirus-19 Transmission Relative to the Other Stigmatized Conditions Opioid Use and Depression

Kelly E. Dunn, A. S. Huhn, Cecilia L Bergeria, 2022, Frontiers in Psychiatry.

Suvorexant ameliorated sleep disturbance, opioid withdrawal, and craving during a buprenorphine taper

E. Strain, Kelly E. Dunn, A. Umbricht, 2022, Science Translational Medicine.

Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States.

G. Oyler, Kelly E. Dunn, A. Umbricht, 2020, JAMA network open.

Attitudes Toward Organ Donation for Persons Who Have a Substance Use Disorder Relative to Other Health Conditions

Kelly E. Dunn, Cecilia L Bergeria, Caitlyn Grubb, 2021, Frontiers in Psychiatry.

Response to Reduced Nicotine Content in Vulnerable Populations: Effect of Menthol Status.

J. Skelly, M. Stitzer, J. Bunn, 2019, Tobacco regulatory science.

Reduced Nicotine Content Cigarettes and Cannabis Use in Vulnerable Populations.

J. Bunn, S. Higgins, S. Heil, 2018, Tobacco regulatory science.